IRIX Stock Analysis: Buy, Sell, or Hold?
IRIX - Iridex Corp
$1.10
-0.02 (-1.79%)
▼
5d:
-2.65%
30d:
-1.79%
90d:
+5.77%
BUY
HIGH Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 11, 2026
28d
Get Alerted When IRIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IRIX shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: IRIX shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: IRIX is currently trading at $1.10, which is considered oversold relative to its 30-day fair value range of $1.11 to $1.17. The stock's valuation (Forward PE: 55.0) is in line with its historical norms (56.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IRIX is in a strong downtrend. Immediate support is located at $1.01, while resistance sits at $1.20.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.75 (+150.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IRIX is in a strong downtrend. Immediate support is located at $1.01, while resistance sits at $1.20.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.75 (+150.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.11 -
$1.17
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 150.0% below Wall St target ($2.75)
Trading Range Analysis
30-Day Trading Range
$1.11 -
$1.17
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.01
Resistance Level
$1.20
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
55.00
Wall Street Target
$2.75
(+150.0%)
Revenue Growth (YoY)
-0.8%
Profit Margin
-6.2%
Valuation Discount vs History
-0.8% cheaper
PE vs Historical
55.0 vs 56.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.8%
(market-implied from PE analysis)
1-Year Target
$1.09
(-1%)
2-Year Target
$1.08
(-2%)
3-Year Target
$1.07
(-2%)
3-Yr Target (if PE normalizes)
(PE: 55→56)
$1.10
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 55.0 to 56.3
Stabilization Target:
$1.13
(+2.4%)
PE Expansion Potential:
+2.4%
Share & Embed Analysis
Last updated: July 13, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$98 | 64 BUY |
